<?xml version="1.0" encoding="UTF-8"?>
<ref id="psb1843-bib-0041">
 <label>41</label>
 <mixed-citation publication-type="miscellaneous" id="psb1843-cit-0041">
  <string-name>
   <surname>Zeng</surname>
   <given-names>YM</given-names>
  </string-name>, 
  <italic>et al</italic> Comparative effectiveness and safety of ribavirin plus interferon‐alpha, lopinavir/ritonavir plus interferon‐alpha and ribavirin plus lopinavir/ritonavir plus interferon‐alpha in in patients with mild to moderate novel coronavirus pneumonia. 
  <italic>Chin Med J</italic> 2020; 5 March. DOI: 10.1097/CM9.0000000000000790.
 </mixed-citation>
</ref>
